Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06586528

Increasing Family Engagement in Critical Care

Increasing Family Engagement in Critical Care: The NGAGE Trial (The NGAGE Trial)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
194 (estimated)
Sponsor
Lady Davis Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary aim of this trial is to evaluate if the NGAGE tool improves care engagement in family members of ICU patients. The secondary objectives are to assess if the NGAGE tool improves communication, care satisfaction, psychological symptoms, and quality of life in family members of ICU patients. The NGAGE trial is a stepped wedge cluster randomized trial of 6 Canadian adult ICUs, involving 194 family members. A family member will be considered anyone with a biological, emotional, or legal relationship with the patient and whom the patient wishes to be involved in their care. There will be random and sequential crossover of clusters from control (phase 1) to intervention (phase 2) until all clusters are exposed. The intervention group will have access to the NGAGE tool, which has modules to Learn, Engage, and Report. "Engage" allows the family member to indicate their desired engagement activity, which is then transmitted to the treating healthcare team to provide the requested activity. "Learn" contains educational capsules about the ICU environment and information about care participation. "Report" allows the family member to provide real-time feedback to the healthcare team. The primary endpoint is the FAMily Engagement (FAME) score within 1 week of ICU discharge. Secondary endpoints are family-centered outcomes, including communication quality, satisfaction, and mental health (anxiety and depression) scores within 1 week of ICU discharge, and quality of life and mental health (anxiety, depression, and post-traumatic distress symptoms) at 6 months. The mean difference of the validated FAME score, a continuous variable, will be compared between groups.

Conditions

Interventions

TypeNameDescription
OTHERNGAGE toolAccess to NGAGE tool

Timeline

Start date
2025-03-26
Primary completion
2026-07-01
Completion
2027-09-01
First posted
2024-09-19
Last updated
2025-05-18

Locations

2 sites across 1 country: Canada

Source: ClinicalTrials.gov record NCT06586528. Inclusion in this directory is not an endorsement.